Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AVNS Avanos Medical	$10.29 +4.1%	$11.99	$9.30 ▼ $25.36	$457.35M	1.12	530,691 shs	1.18 million shs
AXGN AxoGen	$13.75 +0.2%	$11.36	$7.83 ▼ $21.00	$624.86M	1	1.67 million shs	3.51 million shs
KIDS OrthoPediatrics	$17.90 -11.3%	$21.43	$16.59 ▼ $33.14	$490.35M	1.12	163,269 shs	389,207 shs
RCEL Avita Medical	$5.36 +1.5%	$5.53	$4.71 ▼ $14.16	$139.57M	1.63	255,024 shs	215,629 shs

7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AVNS Avanos Medical	+3.13%	-11.73%	-13.29%	-18.06%	-55.12%
AXGN AxoGen	+0.22%	+4.17%	+21.04%	+8.86%	+75.61%
KIDS OrthoPediatrics	-11.34%	-17.44%	-15.73%	-22.44%	-34.34%
RCEL Avita Medical	+1.52%	0.00%	+3.68%	-42.43%	-33.58%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
AVNS Avanos Medical	1.7184 of 5 stars	0.0	3.0	0.0	1.1	1.7	2.5
AXGN AxoGen	2.2907 of 5 stars	3.5	1.0	0.0	2.2	2.5	0.6
KIDS OrthoPediatrics	3.8928 of 5 stars	3.4	1.0	3.9	1.8	3.3	0.6
RCEL Avita Medical	0.8755 of 5 stars	3.4	0.0	0.0	0.0	0.0	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AVNS Avanos Medical	0.00	N/A	N/A	N/A
AXGN AxoGen	3.00	Buy	$24.50	78.18% Upside
KIDS OrthoPediatrics	2.86	Moderate Buy	$36.29	102.71% Upside
RCEL Avita Medical	2.75	Moderate Buy	$16.50	207.84% Upside

Current Analyst Ratings Breakdown

Latest RCEL, AXGN, AVNS, and KIDS Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/6/2025	KIDS OrthoPediatrics	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$40.00 ➝ $39.00
7/14/2025	KIDS OrthoPediatrics	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy
6/6/2025	RCEL Avita Medical	D. Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$19.00
5/13/2025	AXGN AxoGen	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$26.00 ➝ $24.00
5/8/2025	KIDS OrthoPediatrics	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$40.00 ➝ $30.00
5/8/2025	KIDS OrthoPediatrics	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$42.00 ➝ $42.00

(Data available from 8/7/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AVNS Avanos Medical	$692.50M	0.69	$12.40 per share	0.83	$16.79 per share	0.61
AXGN AxoGen	$187.34M	3.34	N/A	N/A	$2.36 per share	5.83
KIDS OrthoPediatrics	$204.73M	2.12	N/A	N/A	$14.64 per share	1.22
RCEL Avita Medical	$64.25M	2.20	N/A	N/A	$0.17 per share	31.53

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AVNS Avanos Medical	-$392.10M	-$10.07	N/A	5.95	N/A	-66.89%	6.16%	4.57%	N/A
AXGN AxoGen	-$9.96M	-$0.10	N/A	N/A	N/A	-2.29%	-4.53%	-2.36%	N/A
KIDS OrthoPediatrics	-$37.82M	-$1.79	N/A	N/A	N/A	-18.92%	-6.35%	-4.75%	N/A
RCEL Avita Medical	-$61.85M	-$2.19	N/A	N/A	N/A	-79.61%	-632.62%	-71.72%	8/7/2025 (Estimated)

Latest RCEL, AXGN, AVNS, and KIDS Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/7/2025	Q2 2025	RCEL Avita Medical	-$0.26	N/A	N/A	N/A	$34.27 million	N/A
8/5/2025	Q2 2025	AVNS Avanos Medical	$0.18	$0.17	-$0.01	-$1.66	$165.50 million	$175.00 million
8/5/2025	Q2 2025	KIDS OrthoPediatrics	-$0.17	-$0.11	+$0.06	-$0.30	$61.40 million	$61.08 million
5/8/2025	Q1 2025	RCEL Avita Medical	-$0.39	-$0.53	-$0.14	-$0.53	$33.15 million	$18.51 million
5/7/2025	Q1 2025	KIDS OrthoPediatrics	-$0.26	-$0.39	-$0.13	-$0.46	$51.68 million	$52.41 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
AVNS Avanos Medical	N/A	N/A	N/A	N/A	N/A
AXGN AxoGen	N/A	N/A	N/A	N/A	N/A
KIDS OrthoPediatrics	N/A	N/A	N/A	N/A	N/A
RCEL Avita Medical	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AVNS Avanos Medical	0.12	2.64	1.56
AXGN AxoGen	0.63	4.28	2.65
KIDS OrthoPediatrics	0.21	6.19	2.99
RCEL Avita Medical	9.39	2.09	1.72

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AVNS Avanos Medical	95.17%
AXGN AxoGen	80.29%
KIDS OrthoPediatrics	69.05%
RCEL Avita Medical	27.66%

Insider Ownership

Company	Insider Ownership
AVNS Avanos Medical	2.64%
AXGN AxoGen	2.78%
KIDS OrthoPediatrics	32.70%
RCEL Avita Medical	2.80%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AVNS Avanos Medical	2,227	46.24 million	45.02 million	Optionable
AXGN AxoGen	450	45.54 million	44.28 million	Optionable
KIDS OrthoPediatrics	200	24.29 million	16.35 million	Optionable
RCEL Avita Medical	130	26.43 million	25.70 million	Optionable

RCEL, AXGN, AVNS, and KIDS Headlines

Recent News About These Companies

Avita Medical (RCEL) to Release Earnings on Thursday

August 1, 2025 | marketbeat.com

AVITA Medical to Announce Second Quarter 2025 Financial Results

July 28, 2025 | globenewswire.com

Avita Medical Ltd (RCEL) Stock Forums - Investing.com

June 30, 2025 | investing.com

AVITA Medical, Inc. (RCEL) - Yahoo Finance

June 27, 2025 | finance.yahoo.com

Analysts Expect Breakeven For AVITA Medical, Inc. (NASDAQ:RCEL) Before Long

June 21, 2025 | finance.yahoo.com

AVITA Medical Announces First Clinical Publication Demonstrating Accelerated Autograft Readiness with Cohealyx™

June 5, 2025 | finance.yahoo.com

AVITA Medical's RECELL Platform Recognized for Surgical Innovation in 2025 MedTech Breakthrough Awards

June 3, 2025 | globenewswire.com

AVITA Medical’s Acute Wound Care Showcase 2025 Streams Live Today

May 13, 2025 | finance.yahoo.com

AVITA Medical: Near-Perfect Execution Needed To Navigate Through Balance Sheet Challenges

May 12, 2025 | seekingalpha.com

Analysts Have Been Trimming Their AVITA Medical, Inc. (NASDAQ:RCEL) Price Target After Its Latest Report

May 11, 2025 | finance.yahoo.com

AVITA Medical, Inc. (RCEL) Q1 2025 Earnings Call Transcript

May 8, 2025 | seekingalpha.com

AVITA Medical Reports First Quarter 2025 Financial Results

May 8, 2025 | globenewswire.com

AVITA Medical to Announce First Quarter 2025 Financial Results

April 17, 2025 | globenewswire.com

AVITA Medical to Present Breakthrough Clinical Data in Burn and Wound Care at ABA 2025

April 9, 2025 | globenewswire.com

6 Analysts Assess AVITA Medical: What You Need To Know

April 6, 2025 | nasdaq.com

Avita Medical announces U.S. commercial launch of Cohealyx

April 4, 2025 | msn.com

AVITA Medical Launches Cohealyx, Supporting Healing and Unlocking New Market Opportunity

April 3, 2025 | globenewswire.com

AVITA Medical’s SWOT analysis: regenerative medicine stock faces growth hurdles

March 21, 2025 | uk.investing.com

4RCEL : What Analysts Are Saying About AVITA Medical Stock

March 18, 2025 | benzinga.com

Avita Medical amends PermeaDerm distribution agreement with Stedical Scientific

March 17, 2025 | markets.businessinsider.com

Avita Medical Boosts Production with New Agreement

March 17, 2025 | tipranks.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

RCEL, AXGN, AVNS, and KIDS Company Descriptions

Avanos Medical NYSE:AVNS

$10.29 +0.40 (+4.06%)

Closing price 08/6/2025 03:59 PM Eastern

Extended Trading

$10.33 +0.04 (+0.37%)

As of 08/6/2025 06:23 PM Eastern

Avanos Medical, Inc., a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides a portfolio of non-opioid pain solutions, including surgical pain and recovery products, such as ON-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy; OrthogenRx's knee osteoarthritis hyaluronic acid pain relief injection products; and Trident radiofrequency ablation products to treat chronic pain conditions. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.

AxoGen NASDAQ:AXGN

$13.75 +0.03 (+0.22%)

Closing price 08/6/2025 04:00 PM Eastern

Extended Trading

$14.23 +0.48 (+3.49%)

As of 08/6/2025 06:08 PM Eastern

AxoGen, Inc., together with its subsidiaries, develops and commercializes technologies for peripheral nerve regeneration and repair worldwide. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments; and Axoguard HA+ Nerve Protector, a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating designed to provide short- and long-term protection for peripheral nerve injuries. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and AxoTouch two-point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. The company provides its products to hospitals, surgery centers, and military hospitals, plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons. AxoGen, Inc. is headquartered in Alachua, Florida.

OrthoPediatrics NASDAQ:KIDS

$17.90 -2.29 (-11.34%)

Closing price 08/6/2025 04:00 PM Eastern

Extended Trading

$17.86 -0.04 (-0.22%)

As of 08/6/2025 07:04 PM Eastern

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIMTM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIROTM Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, and Mitchell Ponseti. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.

Avita Medical NASDAQ:RCEL

$5.36 +0.08 (+1.52%)

Closing price 08/6/2025 04:00 PM Eastern

Extended Trading

$5.36 0.00 (0.00%)

As of 08/6/2025 07:47 PM Eastern

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time